(IUPAC) name[8-methyl-8-(1-methylethyl)- atrovent peanut oct-3-yl] 3-hydroxy-2-phenyl-propanoateIdentifiersCAS number 60205-81-4ATC code R01AX03 R03BB01PubChem 43232DrugBank APRD00537Chemical dataFormula C20H30NO3Mol. mass 389.457 g/molSMILES eMolecules & PubChemPharmacokinetic.

?Protein binding 0 to 9% in vitroMetabolism HepaticHalf life 2 hoursExcretion atrovent peanut atrovent peanut atrovent peanut cat. B(US)Legal status POM(UK)Routes atrovent peanut (as ipratropium bromide, trade name Atrovent) is an anticholinergic drug administered by inhalation for the treatment of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus secretion. It is a quaternary amine and therefore does not diffuse into the blood, which prevents systemic side effects. Ipratropium is also combined with albuterol (salbutamol) atrovent peanut atrovent peanut Combivent and Duoneb) for the treatment of obstructive lung diseases. It acts by blocking muscarinic receptors in the lung, atrovent peanut bronchoconstriction and atrovent peanut secretion. It is a derivative of atropine[1] but is a derivative of atropine[1] but is a non-selective muscarinic antagonist, and does not diffuse into the blood, which prevents systemic side effects. Ipratropium is a derivative of atropine[1] but.

8-azoniabicyclo[3.2.1] oct-3-yl] 3-hydroxy-2-phenyl-propanoateIdentifiersCAS number 60205-81-4ATC code R01AX03 R03BB01PubChem.